Biomerica Inc (BMRA)

Name: Biomerica Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$1.2M

Net Income

-$1.3M

Operating Margin

-113.5%

Free Cash Flow

-$3.9M

Debt / Assets

31.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Biomerica Inc (BMRA).
Income Statement (Quarterly)	2025-11-30	2025-08-31	2025-02-28	2024-11-30
Revenue	1,210,000	1,380,000	1,119,000	1,636,000
Cost of Revenue	1,159,000	956,000	1,100,000	1,199,000
Gross Profit	51,000	424,000	19,000	437,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,231,000	1,330,000	1,012,000	1,173,000
Operating Expenses	1,424,000	1,542,000	1,229,000	1,430,000
Operating Income	-1,373,000	-1,118,000	-1,210,000	-993,000
Interest Expense	0	0	0	0
Income Before Tax	-1,315,000	5,000	-1,167,000	-953,000
Income Tax Expense	5,000	3,000	-4,000	-3,000
Net Income	-1,320,000	2,000	-1,163,000	-950,000
Per Share
EPS	-0.45	0.00	-0.07	-0.06
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Biomerica Inc (BMRA).
Income Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Revenue	5,311,000	5,415,000	5,339,000	18,871,409	7,199,027
Cost of Revenue	4,813,000	4,804,000	4,893,000	15,893,991	6,702,046
Gross Profit	498,000	611,000	446,000	2,977,418	496,981
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	4,612,000	5,487,000	6,085,000	5,698,958	4,608,950
Operating Expenses	5,635,000	6,978,000	7,669,000	7,511,382	7,019,456
Operating Income	-5,137,000	-6,367,000	-7,223,000	-4,533,964	-6,522,475
Interest Expense	0	0	0	26,639	367
Income Before Tax	-4,972,000	-5,936,000	-7,089,000	-4,507,325	-6,455,979
Income Tax Expense	1,000	42,000	51,000	23,719	13,057
Net Income	-4,973,000	-5,978,000	-7,140,000	-4,531,044	-6,469,036
Per Share
EPS	-2.16	-0.36	-0.50	-0.36	-0.54
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Biomerica Inc (BMRA).
Balance Sheet (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Assets
Cash and Cash Equivalents	2,399,000	4,170,000	9,719,000	5,916,983
Short Term Investments	0	0	0	0
Net Receivables	731,000	947,000	722,000	773,818
Inventory	1,490,000	2,376,000	2,056,000	2,416,000
Total Current Assets	4,875,000	7,731,000	12,797,000	9,427,531
Property Plant Equipment	564,000	943,000	1,248,000	1,515,474
Goodwill and Intangibles	228,000	212,000	165,000	170,000
Total Assets	5,945,000	9,254,000	14,454,000	11,374,280
Liabilities
Account Payables	295,000	288,000	344,000	736,000
Short Term Debt	358,000	326,000	297,000	341,296
Total Current Liabilities	1,740,000	2,204,000	1,945,000	2,011,282
Long Term Debt	100,000	459,000	785,000	1,038,284
Total Liabilities	1,840,000	2,663,000	2,730,000	3,049,566
Shareholders Equity
Retained Earnings	-53,168,000	-48,195,000	-42,217,000	-35,077,379
Total Shareholders Equity	4,105,000	6,591,000	11,724,000	8,324,714

Balance sheet annual history for Biomerica Inc (BMRA).
Balance Sheet (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Assets
Cash and Cash Equivalents	2,399,000	4,170,000	9,719,000	5,916,983	4,199,311
Short Term Investments	0	0	0	0	0
Net Receivables	731,000	947,000	722,000	773,818	1,455,051
Inventory	1,490,000	2,376,000	2,056,000	2,416,000	3,206,000
Total Current Assets	4,875,000	7,731,000	12,797,000	9,427,531	9,230,907
Property Plant Equipment	564,000	943,000	1,248,000	1,515,474	1,863,601
Goodwill and Intangibles	228,000	212,000	165,000	170,000	294,830
Total Assets	5,945,000	9,254,000	14,454,000	11,374,280	11,818,813
Liabilities
Account Payables	295,000	288,000	344,000	736,000	431,621
Short Term Debt	358,000	326,000	297,000	341,296	327,944
Total Current Liabilities	1,740,000	2,204,000	1,945,000	2,011,282	1,300,220
Long Term Debt	100,000	459,000	785,000	1,038,284	1,291,570
Total Liabilities	1,840,000	2,663,000	2,730,000	3,049,566	2,591,790
Shareholders Equity
Retained Earnings	-53,168,000	-48,195,000	-42,217,000	-35,077,379	-28,394,768
Total Shareholders Equity	4,105,000	6,591,000	11,724,000	8,324,714	9,227,023

Cash flow quarterly history for Biomerica Inc (BMRA).
Cash Flow Statement (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Operating Activities
Net Income	-4,973,000	-5,978,000	-7,140,000	-4,531,044
Depreciation & Amortization	400,000	374,000	351,000	594,821
Stock Based Compensation	460,000	837,000	1,185,000	1,260,195
Change in Working Capital	268,000	-625,000	-38,000	2,914,645
Operating Cash Flow	-3,841,000	-5,361,000	-5,474,000	-480,532
Investing Activities
Capital Expenditure	-37,000	-115,000	-78,000	-170,336
Investments	-37,000	-51,000	-78,000	-170,336
Investing Cash Flow	-37,000	-115,000	-78,000	-170,336
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	2,143,000	-81,000	9,309,000	2,317,160
Dividends Paid	0	0	0	0
Financing Cash Flow	2,111,000	-81,000	9,390,000	2,394,520
Summary
Free Cash Flow	-3,878,000	-5,476,000	-5,552,000	-650,868
Net Change in Cash	-1,770,000	-5,549,000	3,802,000	1,717,672

Cash flow annual history for Biomerica Inc (BMRA).
Cash Flow Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Operating Activities
Net Income	-4,973,000	-5,978,000	-7,140,000	-4,531,044	-6,469,036
Depreciation & Amortization	400,000	374,000	351,000	594,821	375,855
Stock Based Compensation	460,000	837,000	1,185,000	1,260,195	377,391
Change in Working Capital	268,000	-625,000	-38,000	2,914,645	-1,852,986
Operating Cash Flow	-3,841,000	-5,361,000	-5,474,000	-480,532	-5,251,748
Investing Activities
Capital Expenditure	-37,000	-115,000	-78,000	-170,336	-295,583
Investments	-37,000	-51,000	-78,000	-170,336	-135,856
Investing Cash Flow	-37,000	-115,000	-78,000	-170,336	-295,583
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	2,143,000	-81,000	9,309,000	2,317,160	1,011,475
Dividends Paid	0	0	0	0	0
Financing Cash Flow	2,111,000	-81,000	9,390,000	2,394,520	1,113,730
Summary
Free Cash Flow	-3,878,000	-5,476,000	-5,552,000	-650,868	-5,547,331
Net Change in Cash	-1,770,000	-5,549,000	3,802,000	1,717,672	-4,441,716